WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002032408) COMBINATIONS OF A THYROMIMETIC COMPOUND AND A STATIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/032408    International Application No.:    PCT/EP2001/012075
Publication Date: 25.04.2002 International Filing Date: 18.10.2001
Chapter 2 Demand Filed:    23.04.2002    
IPC:
A61K 31/365 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NL, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
STEELE, Ronald, Edward [US/US]; (US) (For US Only).
DARDIK, Beatriz, N. [US/US]; (US) (For US Only)
Inventors: STEELE, Ronald, Edward; (US).
DARDIK, Beatriz, N.; (US)
Agent: BECKER, Konrad; Novartis AG, Corporate Intellectual Property, Patent & Trademark Dept., CH-4002 Basel (CH).
GROS, Florent; NOVARTIS AG, Patent & Trademark Department, 4002 Basel (CH)
Priority Data:
60/242,036 20.10.2000 US
Title (EN) COMBINATIONS OF A THYROMIMETIC COMPOUND AND A STATIN
(FR) COMPOSITIONS
Abstract: front page image
(EN)Disclosed are methods for the treatment of conditions associated with elevated levels of Lp(a), such as CHD, ischaemic stroke, restenosis after angioplasty, peripheral vascular disease, intermittent claudication, reduction in necrosis after myocardial infarction, dyslipidemia and post−prandial lipemia. The methods include administration of a therapeutically effective amount of a pharmaceutical combination of a thyromimetic compound and a statin.
(FR)Cette invention se rapporte à des procédés servant à traiter des états associés à des niveaux élevés de Lp(a), tels que coronaropathie, attaque ischémique, resténose après une angioplastie, maladie vasculaire périphérique, claudication intermittente, réduction de nécrose après infarctus du myocarde, dyslipidémie et lipémie post-prandiale. Ces procédés consistent à administrer, en quantité thérapeutiquement efficace, une combinaison pharmaceutique d'un composé thyromimétique et d'une statine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)